WHITE PAPER

Dense Breast Tissue and the Cancer Screening Gap

A Primer for Women's Health Providers

Download White Paper

Dense breast tissue affects up to 50% of women who undergo mammography.¹ In this new white paper, learn why mammograms are less effective at diagnosing early cancer among this population, and discover in-office imaging alternatives that improve outcomes and the patient experience.

Download Now

Complete the form below to access the full white paper.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Reimagine In-Office Breast Imaging

SOFIA is an innovative, FDA-cleared ultrasound screening technology specifically designed for early detection of cancer in dense breast patients.

Effective: Up to 2x more accurate diagnosis results for patients with dense breast tissue²
Efficient: Cost-effective and profitable in-office procedure performed by your existing team
Comfortable: A better patient experience, without compression, injections, or radiation

Discover if SOFIA is right for your practice by scheduling a virtual or in-person consultation - just complete the form to get started.

Learn if SOFIA is right for your practice with an in-person or virtual demo.

Schedule a Demo
  1. National Cancer Institute, 2025: Dense Breasts: Answers to Commonly Asked Questions.
  2. Journal of Personalized Medicine, 2021: Second-Generation 3D Automated Breast Ultrasonography (Prone ABUS) for Dense Breast Cancer Screening Integrated to Mammography: Effectiveness, Performance and Detection Rates.